发明名称 PHARMACEUTICAL CONTAINING GLYCINE TRANSPORTER INHIBITOR
摘要 PROBLEM TO BE SOLVED: To provide an agent for preventing or treating disorders such as schizophrenia, Alzheimer's disease, cognitive dysfunction, cognition disease, anxiety disorder (generalized anxiety disorder, panic disorder, obsessive compulsive disorder, social anxiety disorder, post traumatic stress disorder, specific phobia, acute stress disorder or the like), melancholia, drug dependence, seizure, tremor, and somnipathy or the like based on glycine capture disruption action. SOLUTION: The agent for preventing or treating disorders selected from a group consisting of schizophrenia, Alzheimer's disease, cognitive dysfunction, cognition disease, anxiety disorder, melancholia, drug dependence, seizure, tremor, somnipathy includes compounds expressed by formula [I] or salts or hydrates thereof which are pharmaceutically permitted as active ingredients. COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009185010(A) 申请公布日期 2009.08.20
申请号 JP20080029724 申请日期 2008.02.08
申请人 TAISHO PHARMACEUTICAL CO LTD 发明人 SEKIGUCHI YOSHIISA;SHIBATA TAKESHI;ABE KIMIYOSHI;YAMAMOTO SHUJI;KASHIWA SHUHEI;OKUBO TAKETOSHI
分类号 A61K31/4155;A61K31/4439;A61K31/445;A61K31/4525;A61K31/454;A61K31/4545;A61K31/4709;A61K31/497;A61K31/506;A61P25/08;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P43/00;C07D211/26;C07D401/10;C07D401/12;C07D401/14;C07D403/10;C07D405/10;C07D405/14;C07D409/14;C07D413/10;C07D417/14 主分类号 A61K31/4155
代理机构 代理人
主权项
地址